Nasdaq agrx.
Apr 19, 2022 · Agile Therapeutics (NASDAQ: AGRX), a women's healthcare company, reported increasing Twirla prescription data for the first quarter 2022.Twirla cycles dispensed increased 29% to 16,602; Total ...
Find the latest Insider Activity data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.PRINCETON, N.J., July 23, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of ...PRINCETON, N.J., May 25, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the closing of its ...NASDAQ. NASDAQ pulled back as traders took profits in tech stocks. NVIDIA is down by 3.3% as traders worry that company’s sales in China would decline …Sep 27, 2023 · Maxim Group, a major investment bank, conducts and publishes stock analysis through its Equity Research team. The team has a strong reputation in the industry; a host of major firms use its ...
PRINCETON, N.J., July 18, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the appointment of Dennis P. Reilly as Chief Financial ...Agile Therapeutics Inc (NASDAQ:AGRX) ... Institutional investors purchased a net $3.4 thousand shares of AGRX during the quarter ended June 2019 and now own 7.67% ...
PRINCETON, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today applauded House Congressional Committee leaders in urging the ...PRINCETON, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it has received a notification letter from the ...
Investor Relations. Agile Therapeutics® is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet needs of today’s women. Our product and product candidates are designed to offer women more freedom and flexibility through additional contraceptive options.PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today reported financial results for the three months ended June 30 ...PRINCETON, N.J., April 14, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced Twirla prescription data for the first quarter 2022.Agile Therapeutics Inc. (NASDAQ: AGRX) During trading and after-hours, AGRX stock managed to shoot up by over 10% and 10.4% respectively. And, this is even more impressive following its six month drop of over 90%. For similar reasons that EVFM stock climbed, AGRX is a women’s health focused biotech penny stock.Agile Therapeutics, Inc. (NASDAQ: AGRX), the commercial-stage women’s healthcare company, posted a 122% increase in third-quarter revenue year-over-year, driven by strong demand for TwirlaⓇ ...
Agile Therapeutics, Inc. (NASDAQ:AGRX) is a New Jersey-based healthcare company focused on catering to the unmet demands of women by offering them various contraceptive options.
AGRX Agile Therapeutics Inc Agile Therapeutics Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price Requirement PRINCETON, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ('Agile' or the 'Company'), a women's healthcare company, today announced that it has received written noti...
Agile Therapeutics (AGRX) Q1 2022 Earnings Call Transcript. Mar 30, 2022. PRINCETON, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced that Al Altomari, Chairman and Chief ...PRINCETON, N.J., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it will participate in the RHK Capital Disruptive ...PRINCETON, N.J., July 12, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new ...PRINCETON, N.J., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairperson and Chief Executive Officer Al Altomari and Chief Commercial Officer Amy Welsh will present at the H.C.... Twirla Delivers Second Quarter 2023 Net Revenue of …Feb 27, 2023 · PRINCETON, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile” or the “Company”), a women's healthcare company, today announced that it has received ... Nov 30, 2023 · The latest price target for Agile Therapeutics ( NASDAQ: AGRX) was reported by Maxim Group on Friday, September 22, 2023. The analyst firm set a price target for 5.00 expecting AGRX to rise to ...
AGRX has an Altman Z-Score of -49.72 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for Agile Therapeutics, Inc. (AGRX) stock, including valuation metrics, financial numbers, share information and more.Agile Therapeutics Inc. (NASDAQ: AGRX) Avadel Pharmaceuticals Plc (NASDAQ: AVDL) Venator Materials Plc Agile Therapeutics Inc. (NASDAQ: AGRX) Agile Therapeutics is one of the bigger gainers so far today with over 19% in gains during morning trading. This comes after a five day and one month drop of more than 19% and over 45%.PRINCETON, N.J., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that it intends to offer and sell shares of its common ...XBiotech Inc. (NASDAQ:XBIT) said its board has declared an extraordinary cash dividend of approximately $2.50 per share, or up to an aggregate of $75 million, to holders of its common stock. This ...The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”View the latest Agile Therapeutics Inc. (AGRX) stock price, news, historical charts, analyst ratings and financial information from WSJ.Sep 27, 2023 · Maxim Group, a major investment bank, conducts and publishes stock analysis through its Equity Research team. The team has a strong reputation in the industry; a host of major firms use its ...
Stock analysis for Agile Therapeutics Inc (AGRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.The Company’s common stock will open for trading on the Nasdaq Capital Market on Tuesday, April 11, 2023 on a split-adjusted basis under the current trading symbol "AGRX." The reverse stock ...
(NASDAQ: AGRX) forecast ROE is N/A, which is considered weak. What is AGRX's Price Target? According to 2 Wall Street analyst s that have issued a 1 year AGRX price target, the average AGRX price target is $8.50 , with the highest AGRX stock price forecast at $12.00 and the lowest AGRX stock price forecast at $5.00 . Agile Therapeutics (NASDAQ:AGRX – Get Free Report) last released its quarterly earnings results on Thursday, November 9th. The specialty pharmaceutical company reported ($1.47) EPS for the quarter.Agile Therapeutics (NASDAQ: NASDAQ: AGRX) is a women’s healthcare company focused on patch-based contraceptive options. Their lead product, Twirla, is a once-a-week contraceptive patch ...PRINCETON, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced that Al Altomari, Chairman and Chief ...PRINCETON, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2022 ...Find the latest Earnings Report Date for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com. Shares of NASDAQ AGRX opened at $2.16 on Friday. Agile Therapeutics has a one year low of $1.65 and a one year high of $16.00. The firm has a market …Company now focused on completing plan to resubmit NDA in first half of 2019. PRINCETON, N.J., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women’s healthcare ...Find the latest Earnings Report Date for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.Agile Therapeutics, Inc. (NASDAQ: AGRX), the commercial-stage women’s healthcare company, posted a 122% increase in third-quarter revenue year-over-year, driven by strong demand for TwirlaⓇ ...
The Nasdaq is up 3,719.01 points, or 35.5%. The Russell 2000 is up 120.77 points, or 6.9%. The Associated Press is an independent global news organization …
Feb 27, 2023 · The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”
Apr 26, 2022 · The Company’s common stock will open for trading on the Nasdaq Market on Wednesday, April 27, 2022 on a split-adjusted basis under the current trading symbol "AGRX." Agile Therapeutics Inc (NASDAQ: AGRX) was in 6 hedge funds' portfolios at the end of the first quarter of 2021. The all time high for this statistic is 15. Our calculations also showed that AGRX ...According to NASDAQ, as of May 2014, the highest NASDAQ closing ever was achieved on March 9, 2000, when the market closed at a record 5046.86. USA Today reports that the highest closing achieved by NASDAQ since was a 4007.09 closing on Nov...Dec 1, 2023 · According to the issued ratings of 2 analysts in the last year, the consensus rating for Agile Therapeutics stock is Buy based on the current 2 buy ratings for AGRX. The average twelve-month price prediction for Agile Therapeutics is $8.50 with a high price target of $12.00 and a low price target of $5.00. Learn more on AGRX's analyst rating ... PRINCETON, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three months ended March 31, 2023 ...The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.According to NASDAQ, as of May 2014, the highest NASDAQ closing ever was achieved on March 9, 2000, when the market closed at a record 5046.86. USA Today reports that the highest closing achieved by NASDAQ since was a 4007.09 closing on Nov...Agile Therapeutics Inc (NASDAQ:AGRX) shares are down by over 99% in the last year and down almost 72% in the last three months. As of this writing, Agile Therapeutics shares are trading at above $0.38 (52-week range of $0.37 to $50.40), giving it a market capitalization of more than $15 million.
Agile Therapeutics (NASDAQ:AGRX – Get Free Report) last released its quarterly earnings results on Thursday, November 9th. The specialty pharmaceutical company reported ($1.47) EPS for the quarter.PRINCETON, N.J., April 20, 2021 (GLOBE NEWSWIRE) -- In a release issued earlier today by Agile Therapeutics, Inc. (Nasdaq: AGRX), please note the headline should read "Agile Therapeutics to Report ...Apr 10, 2023 · The Company’s common stock will open for trading on the Nasdaq Capital Market on Tuesday, April 11, 2023 on a split-adjusted basis under the current trading symbol "AGRX." Agile Therapeutics (NASDAQ:AGRX – Get Free Report) last released its quarterly earnings results on Thursday, November 9th. The specialty pharmaceutical company reported ($1.47) EPS for the quarter.Instagram:https://instagram. zillow group stockwhy nvda stock downautozone temustyrker stock PRINCETON, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it has received a notification letter from the ... dividend increases this weekspi solar PRINCETON, N.J., March 14, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced that it has ... is groundfloor a good investment Jun 28, 2022 · Agile Therapeutics (NASDAQ: AGRX), a women's healthcare company, reported increasing Twirla prescription data for the first quarter 2022.Twirla cycles dispensed increased 29% to 16,602; Total ... PRINCETON, N.J., June 16, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that the Company will be added to the Russell 3000® and ...